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Lymphedema is the swelling of soft tissues as a result of the accumulation of protein-rich
fluid in extracellular spaces. Secondary lymphedema is precipitated by an event causing
blockage or interruption of the lymphatic vessels. Secondary lymphedema is a potential
complication that may affect the quality of life of patients treated for breast cancer. Life-
long risk factors of post-breast cancer lymphedema are related to the extent of axillary
node involvement, type of breast surgery, and radiation therapy. These factors decrease
lymphatic drainage and increase stasis of fluids in the areas of skin and subcutaneous
tissues that drain to regional lymph nodes. Breast cancer-related lymphedema can involve
the arm and hand, as well as the breast and trunk on the operative side. Clinical symptom
assessment and circumferential measures are widely used to evaluate lymphedema.
Treatment of lymphedema associated with breast cancer can include combined modality
approaches, compression therapy, therapeutic exercises, and pharmacotherapy.
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1. Introduction
Breast cancer has been the focused of many studies because it
significantly affects both in developed and developing coun-
tries worldwide. In 2012, about 1.7 million women worldwide
were diagnosed with breast cancer and 521,900 cases died
from this disease [1]. The American Cancer Society reported
that approximately 231,840 new cases of invasive breast
cancer are expected to be diagnosed among women in the
USA in 2015; this organization also predicted that 60,290 new
cases of in situ breast cancer and 40,290 breast cancer deaths
would occur in 2015 [2]. The 5-year relative survival of women
diagnosed with breast cancer has increased from 80% in the
1950s to 89% today relative to age-matched women without
the disease [2].
Although breast cancer treatments, including surgery,
radiotherapy, chemotherapy, and hormonal therapy, have
improved patient outcomes, these techniques cause patients
to potentially suffer substantial adverse effects [3]. One
complication of these treatments is lymphedema, a chronic
health problem, troublesome to both patients and health
professionals. Lymphedema describes a set of pathological
conditions, in which protein-rich fluid accumulates in soft
tissues because of interruption of lymphatic flow [4]. Lym-
phedema is most commonly found in the extremities but can
also be found in the head, neck, abdomen, lungs, and genital
regions [5]. Although the incidence of breast cancer-related
lymphedema (BCRL) remains unclear because of differences
in diagnostic criteria, the different characteristics of the pa-
tients and their inadequate follow-up delayed the de-
velopments in treatment of the disorder [6]. The overall
incidence of upper extremity lymphedema ranges from 8% to
56% 2 years post-surgery [7]. The incidence of breast and
truncal lymphedema has been rarely reported. Jeffs [8] re-
ported a 13% incidence of breast/truncal lymphedema in 168
patients. This study was conducted to refresh the under-
standing of nurses and public health personnel on breast
cancer-related lymphedema.
This article is divided into 55 parts, which include patho-
physiology of lymphedema, risks and causes of lymphedema,
diagnosis of lymphedema, treatment of lymphedema, and
nursing implications.2. Pathophysiology of lymphedema
The lymphatic system maintains fluid balance in tissues,
fights infection, and assists in removal of cellular debris and
waste products from extracellular spaces. Under normal
conditions, the lymphatic system is involved in production of
immune cells and antibodies, destruction of red cells, and
lymph transport. The lymphatic system is divided intorating vessels. The lymphatic system is assumed to function
independently [5]. The superficial transport lymphatic vessels
lie in subcutaneous tissues to provide drainage for the skin
and subcutaneous tissues; moreover, deep transport
lymphatic vessels lie near deeper blood vessels to provide
drainage from muscles, tendon sheaths, nervous tissues,
periosteum, and most joint structures [5]. Lymph from the
lower body below the diaphragm and the left side of the body
above the diaphragm is transported by the thoracic duct,
which is the largest lymph vessel in the body. The thoracic
duct empties into the left venous angle, which is formed by
the left subclavian and left jugular veins. Lymph from the
right side of the body above the diaphragm is transported by
the right lymphatic duct, which empties into the right venous
angle formed by the junction of the right subclavian and right
jugular veins [9].
Fluids normally diffuse into interstitial spaces at the arte-
riolar end of the capillary and filter back into the capillary at
the venular end. Up to 90% of fluids filtered into the inter-
stitium from capillaries are reabsorbed into the venous side.
The remaining 10% (or more) of fluids and proteins are
removed from the interstitium by small, terminal (one-way)
lymphatic vessels [10]. The normal outward flow of fluids
slightly exceeds the inward flow, and the net filtrate enters the
lymphatics and drains back into the bloodstream. This pro-
cess creates stable interstitial pressure. If large molecules
accumulate, such as in obstructed lymph transport because of
axillary treatment, sufficient effective osmotic pressure de-
velops and causes excessive fluids in the interstitial space [9].
This protein-rich swelling condition is called lymphedema.3. Risks and causes of lymphedema
Lymphedema that develops after breast cancer treatment is
thought to be related to the extent of axillary node involve-
ment, type of breast surgery, and radiation therapy. These
factors lead to decreased lymphatic drainage and stasis of
fluids in the skin/tissue areas that normally drain to the axilla;
these areas include ipsilateral breast, chest, lateral and pos-
terior upper trunk, arm, and hand [10]. The lymphatic vessels
in the radiation field are constricted after radiation because of
the resultant fibrotic tissue constriction in the vessels [11]. In
addition, radiation damages cells within the nodes, wherein
high dose of radiation may be directed to eradicate malignant
cells. Radiation compromises lymph node function and can
cause a certain degree of lymphedema [11]. Cancer surgery
also results in superficial scarring that inhibits lymphatic flow
across the scar tissue, leading to lymphatic fluid collection
proximal to the scar [19]. Moreover, local infection after sur-
gery or radiation contributes to the development of
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cellular components in the tissues and thus potentially ex-
ceeds the transport capacity in an altered lymphatic system
[11]. These sources of damage inhibit the lymphatic system to
transport the normal amount of fluids and proteins from the
affected area [11]. Other factors, such as obesity and recurrent
cancer, also increase the risk of patients to develop lymphe-
dema [12]. Additional individual predisposing factors associ-
ated with risk for lymphedema development must be further
investigated [12,13].4. Diagnosis of lymphedema
Clinicians do not universally agree onwhatmeasurement and
criteria define lymphedema. However, lymphedema is
commonly diagnosed when a 2 cm difference or more in arm
circumference at a single anatomic level measured or a 200ml
limb volume difference between the affected and non-
affected limbs is observed [4]. Lymphedema is classified as
stage I, II, or III and quantified as mild, moderate, or severe.
Stage I lymphedema pits on the application of pressure but
reverses with limb elevation. Stage II lymphedema no longer
pits on pressure because of excess fat deposition and tissue
fibrosis and no longer reverses with elevation. Stage III lym-
phedema is characterized by progressive swelling with tro-
phic skin changes, including papules, warts, skin folds, tissue
bulges, and often open draining wounds, leading to severe
impairment in mobility and high risk of infection [14].
Diagnosis of lymphedema requires a detailed medical
history and physical examination [15]. Based on patient's
medical history, patients with breast cancer and lymphedema
may report symptoms, such as sensation of arm fullness and
mild discomfort. These symptoms are manifested in the early
stages of the condition. Joint immobility, pain, and skin
changes are noted frequently in the later stages of lymphe-
dema. Such changes may include pitting of tissues, increased
thickness of skin folds, and enlargement of the affected limb
[15]. The history of the present illness should determine when
the onset of symptoms occurred, duration of symptoms, any
triggering events, and the attempted treatments [14,15].
Moreover, the history should include information on past
operation, postoperative complications, radiation treatment,
interval from radiation or surgery to the onset of symptoms,
intervening variables in the presence or severity of symptoms,
history of trauma or infection, and current medications [15].
Physical examination techniques include water displace-
ment volumetry, sequential circumferential arm measure-
ment, infrared laser perometry, and tissue bioelectrical
impedance spectroscopy [15,16]. However, the most common
methods in determining volume in clinical practice are water
displacement and circumferential measurements [15,16].
The most frequently-used method is tape measurement of
arm circumference 10 cm below and 10 cm above either on the
olecranon or the lateral epicondyle; this method can be easily
applied and involves low cost to the patient. Although cir-
cumferences may appear to be a simple measure, control of
intra- and interrater-reliability is difficult [16].
Water displacement is considered the “gold standard” for
volumetric measurements and incorporates volumetricmeasurements of the hand or foot in the total limb volume
measurement [16]. Although water volume method is accu-
rate, this technique does not provide information on the
shape of the extremity, cannot be used with open wounds,
and can be time-consuming and cumbersome to perform
[15,16].
Three other less commonly used clinical measures are
adopted in this study. A perometer is an optoelectronic device
used to rapidly, hygienically, and accurately calculate volume
calculation and works similarly to a computer-assisted to-
mography but uses infrared light instead of X-rays [16,17].
Tonometry measures tissue resistance instead of volume and
determines the extent of tissue fibrosis [18]. At early lym-
phedema, bioelectrical impedance spectroscopy is used to
measure tissue resistance to electrical current to evaluate
extracellular fluid volume that may not be detectable with
tape measure or visual inspection [16].
Other quantitative measures involve radiological imaging
studies, such as computed tomography, magnetic resonance
imaging, ultrasonography, lymphoscintigraphy, and lymph-
angiography [15,19]. Both computed tomography and mag-
netic resonance imaging show a distinctive honey-comb
pattern within the lymphatic system; this pattern can differ-
entiate lymphedema from other potential cancer-related
causes of edema, such as deep vein thrombosis [19]. Lymph-
angiography was used extensively in the past as an imaging
technique but is associated with inflammation, scarring, and
atrophy of lymph vessels, resulting in impaired lymph trans-
port capacity [19]. Lymphoscintigraphy is a method of injec-
tion of a radioactive tracer into the subdermal region of the
affected limb combined with monitoring with a gamma
camera; this technique is preliminary used to predict patients
with increased risk for lymphedema after axillary treatment
[19]. Lymphoscintigraphy can identify pathways of lymphatic
drainage, dermal backflow, collateral lymph channels, num-
ber of lymph nodes, and clearance times of radiopharma-
ceutical agents [19].
In conclusion, lymphedema diagnostic methods vary. Each
method presents its own appropriateness for application in
clinical practices. For example, water displacement method is
the most reliable (“gold standard”) method for measuring
edematous arms and legs but is not practical for patients with
wounds. Circumferential measurement is a simple and low
cost technique but cannot directly calculate limb volume and
is subject to inter- and intra-rater reliability issues. The high
cost of perometry limits its application, although it can
calculate limb volume quickly and accurately. Finally, bio-
pedance can detect subclinical swelling but has ongoing costs
for disposable electrides; radiological imaging may not be
practical because of their high costs unless causation and
management require further investigation. Consequently,
assessment method needs to be carefully selected depending
on clinical and research settings as well as targeted patient
outcomes.5. Effect of lymphedema
Lymphedema is a chronic condition that has a lifelong effect
on the quality of life of cancer survivors. Previous studies
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with decreased quality of life, particularly in physical func-
tioning, such as functioning in a domestic environment in the
long term [20e22]. Kwan, Jackson, Weir, Dingee, McGregor,
and Olivotto [23] reported that patients with lymphedema
presented decreased quality of life compared with survivors
without lymphedema. In addition, lymphedema confers
tremendous physical, psychological, social, spiritual, and
emotional costs on breast cancer survivors with this chronic
condition [24,25]. Although swelling or edema within the tis-
sue is not in itself painful, stretching of nerve fibers within the
skin, presence of a localized infection, or fluid collection that
causes compression on top of a nerve bundle can result in
significant discomfort and disability. Following the onset of
limb swelling, the patient is predisposed to infection, cellu-
litis, and lymphangitis, which are sometimes followed by life-
threatening septicemia [26]. Armer, Radina, Porock, and Cul-
bertson [27] pointed out that “aching,” “heaviness,” “tight-
ness,” and “pulling” are adjectives commonly used by patients
to describe their discomfort that may be present before visible
signs of swelling are noticed. Moreover, pain can be significant
and troublesome for individuals with BCRL. For example,
Paskett and Stark [28]indicated that about 72% of the re-
spondents report pain in addition to edema. Moreover, when
asked in what ways lymphedema interfere with particular
aspects of daily living, womenmost often report that clothing
and appearance are negatively affected by the condition, fol-
lowed by effect on daily routine and activities [28]. Further-
more, one of the major problems identified by women is the
necessity to wear compression sleeves; they described this
experience as ugly, terrible, un-feminine, and uncomfortably
warm, particularly in summertime because of the need to
conceal their arms by wearing special clothing [29].6. Treatment of lymphedema
Treatment of lymphedema associated with breast cancer can
include combined modality approaches, compression ther-
apy, therapeutic exercises, and pharmacotherapy [19].
Complete decongestive therapy (CDT), a multi-modality
approach, is the “gold standard” for lymphedema treatment.
This therapy includes various techniques, such as manual
lymphatic drainage (MLD), external compression garments
and bandages, skin care, and exercises guided by specially-
trained therapists [5,19]. CDT includes two phases. In Phase
I, acute management is performed in an out-patient clinical
setting. This phase aims to reduce the size of the extremity,
reverse any distortion in the shape, soften the subcutaneous
tissue, and improve the overall health of the skin [5]. On
average, this phase consists of a 4-week program of manual
lymphatic drainage, multi-layer short-stretch compression
bandaging, exercise, and proper skin and nail care [19]. Phase
II is conducted at home by the patient and/or family and in-
volves continued proper skin care and exercise, simple (or
self-) manual lymphatic therapy, and use of a compression
sleeve and glove during the day and compression bandaging
at night [19]. This phase aims tomaintain the achievements of
the first phase and requires life-long commitment by the pa-
tient [5].Compression therapy includes compression bandages or
compression garments, which assist the muscle pump in the
area to be compressed to mobilize lymphatic fluid [19]. The
use of pneumatic compression therapy is widely debated. This
form of therapy can reduce swelling and may be indicated as
adjunctive therapy when self-MLD is difficult for the patient.
However, this technique can lead to a displacement of fluid
elsewhere in the body with the possibility of future problems
[5].
Skin and nail care is essential to prevent infection [5]. Skin
care includes keeping the extremities clean and dry, applying
pH-neutral moisturizer to prevent chapping, and protecting
exposed skin with sunscreen. Moreover, as much as possible,
patients should avoid any puncture wounds, such as in-
jections and blood-drawing on the at-risk/affected limbs. In
addition, patients should avoid using razors that may cause
skin injury in the affected area [30].
Therapeutic exercises are a recognized component of
lymphedema management and include remedial exercises
with the garment or bandage in place to facilitate lymphatic
flow through repeated contraction and relaxation of muscles
[19]. Exercise involving the affected arm, shoulder girdle, and
trunkmay be beneficial in controlling lymphedema. Although
some clinicians have recommended avoidance of rowing,
tennis, golf, skiing, squash, racquetball, or any vigorous, re-
petitivemovements against resistance, no published evidence
from rigorously-conducted studies suggests that these activ-
ities promote or worsen lymphedema [31].
Manual lymphatic drainage is a delicate massage tech-
nique that stimulates lymph vessels to contract frequently
and directs and channels lymph and edema fluids toward
adjacent lymphatic vessels [16]. The pressure applied is very
gentle, and the movements are slow to correspond with
naturally slow, rhythmic lymphatic pulsations [16]. Multi-
layered low-stretch compression bandaging is applied
immediately after manual lymph drainage. Bandages are
wrapped from the fingertips to the axilla in layers to create
high pressure gradient at the most distal part of the limb
that gradually decreases proximally [32]. In mild edema, in
Stages I and II, a compression garment may be used instead
of bandages [24]. Proper fit and function of a compression
garment are essential and need to be tailored to the
individual. An ill-fitting compression garment is worse than
no compression at all. In this case, “one size does not fit
all.”7. Nursing implications
Lymphedema, associated with swelling and pain, is a signifi-
cant problem among breast cancer survivors. As such, nurses
should understand this complex problem to inform their
breast cancer patients of the lifelong risk of developing this
complication [10]. To reduce/prevent lymphedema, nurses
should educate breast cancer survivors to follow self-care
regimen for controlling symptoms and avoiding exacerba-
tion; recommendations include performing daily skin care,
wearing gloves during activities to prevent skin breaks, pre-
venting injury in the affected side, preventing muscle strain,
and promoting lymph drainage (i.e., elevate the affected arm,
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optimal body weight, and wear a well-fitted compression
garment when traveling by air) [25]. In addition, the current
best practice management for lymphedema, including
compression either by garments, bandages or sleeve, manual
lymphatic drainage, massage, exercise, and skin care, should
be explained to deal with lymphedema effectively [16]. With
increasingly brief hospital stays associated with breast cancer
treatment, nurses should teach patients how to reduce risk or
cope with lymphedema; this information can make a differ-
ence in patient recovery and should be reinforced in the out-
patient setting during survivorship follow-up [33]. When pa-
tients understand the pathophysiology of their condition, they
can devise creative ways to deal with the manifestations of
the disease or problem-solve a way to include lymphedema
management into a schedule that maintains function as long
as possible [34]. Until further research is conducted and sci-
ence discovered methods to reduce risk for lymphedema,
patient education is the best tool that health professionals can
use to reduce risk of developing this condition or decreasing
its severity [10].
Lymphedema management among breast cancer survi-
vors is based on results from case studies, clinical experi-
ence, and anecdotal information. However, this
information is less understood and needs further study [31].
As a result, further rigorous studies must be performed.
Currently, much of the focus of education deals with rec-
ommendations for risk reduction that are not yet based on
empirical evidence. Future research is therefore needed on
risk-reduction strategies in women at risk because of breast
cancer treatment [32,35]. In addition, future research
should address the influence of patients' level of accurate
understanding on lymphedema and their choices of effec-
tive and appropriate treatment techniques to better un-
derstand the needs of patients with lymphedema [32,35,36].
Johansson, Holmstrom, Nilsson, Ingvar, Albertsson, and
Ekdahl [29] pointed out that “future research needs to focus
on coping strategies and how they can be strengthened in
the women with lymphedema.” In addition, the relation-
ship of exercise in women with lymphedema is not
completely clear. Hence, additional research is needed to
address this interaction [37]. Furthermore, breast cancer
patients are at a lifetime risk of developing lymphedema
and need more education and counseling about their con-
dition. Further research is needed to develop an educational
and counseling component that will improve patient
knowledge and understanding of lymphedema. Moreover, a
previous study reported that women with lymphedema
travel in different places to find help [38]. During this
wandering period, they might obtain useful information
and secondary gain but they might also lose more than they
gain because of time and money wasted. Studies should
also address health-seeking behavior of patients that might
be different in various societies. Future research should
focus on identification of barriers regarding lymphedema
management in breast cancer survivors with different cul-
tural and ethnic backgrounds by using phenomenological
approaches [39].8. Conclusion
Lymphedema in breast cancer survivors is a relatively com-
mon condition that remains under-recognized by health care
providers. Patients with upper extremity, breast, or truncal
edema secondary to breast cancer therapy experience a sub-
stantial degree of functional impairment, psychological
morbidity, and diminished quality of life. Lymphedema
management aims to prevent the progression of the disease,
reduce edema, maintain edema reduction, alleviate symp-
toms, prevent infection, improve patients'mobility and ability
to perform activities of daily living, and improve overall psy-
chological well-being [5]. Nurses are key members of the
health care teamwho need to knowwhat lymphedema is and
how tomanage it. Therefore, nurses must be trained to assess
emergence and progression of lymphedema, as well as to
educate patients throughout their treatments for appropriate
individualization of management planning. For example,
during the peri-operative period, nurses can educate patients
regarding risk-reduction strategies as well as signs and
symptoms of lymphedema. In addition, further education and
rigorous clinical trials are needed to address the importance of
early recognition and management of lymphedema after
breast cancer treatment. A prospective surveillance program
integrated into the clinical setting is recommended as the
emerging standard of care.r e f e r e n c e s
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